ONCS News and Press, OncoSec Medical Incorporated From 02/10/20

  Transaction Provides Immediate Cash Infusion of $30M at Premium to Market Price of $2.50/share OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announce...

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that, at its Special Meeting of Shareholders (the “Special Meeting”), based on a preliminary ...

Court Rules in Favor of OncoSec – Special Meeting of Shareholders Will Proceed as Planned Today OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today commen...

SAN DIEGO and PENNINGTON, N.J. , Feb. 4, 2020 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced the publication of data showing that TAVO™ (plasmid-based interleu...

Questions Entrenched OncoSec Board and Management’s Rejection of Alpha’s Superior Offer Cautions OncoSec Stockholders Not to Be Deceived by Company’s Distortions and Manipulations Reminds OncoSec Stockholders that $4.50 per Share from China Grand is Not ...

SAN DIEGO and PENNINGTON, N.J. , Feb. 3, 2020 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (Nasdaq: ONCS), a company developing late-stage intratumoral cancer immunotherapies, today announced data from a feasibility study of its visceral lesion applicator (VLA) electrop...

Amid All the Noise of the Proxy Fight, It is Time to Go Back to the Basic Facts about Why the CGP/Sirtex Transaction Is Essential to the Company’s Future Alpha Seems to be Trying to Gain Control of OncoSec on the Cheap Vote on the WHITE Proxy Card, Regardless of Suppor...

Alpha’s Latest Release Merely Resurfaces Earlier “Proposal” in its Entirety, Just with a New Expiration Date – This is Meaningless and Does Nothing to Improve its Poor, Contingency-Laden Terms ALL Shareholders are Entitled to Have Their Votes Count at Speci...

Gainers: Cleveland BioLabs (NASDAQ: CBLI )  +150% . More news on: Cleveland BioLabs, Inc., Lianluo Smart Limited, NanoViricides, Inc., Stocks on the move, , Read more ...

  Provides $9.3 Million in Additional Value Compared with China Grand Takeover and Gives Stockholders the Opportunity to Receive a Cash Premium Binding Term Sheet Expires on February 1 Stockholders who Oppose China Grand Takeover Must Vote on BLUE Card Only Alpha Ho...